For the study, published Oct. 16 in The Journal of Clinical Investigation, researchers exposed breast cancer cells from mice and lung cancer cells from humans to carcinogens. They found the cancer cells were unable to create an immunosuppressive tumor microenvironment, which allowed the body’s immune response to reject the cancer.
The discovery could create a new pathway for increasing the effectiveness of immunotherapy treatments.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
